F. Blows

Astronomical algorithms for automated analysis of tissue protein expression in breast cancer

E Provenzano, C Caldas, C. Caldas, 2013, British Journal of Cancer.

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

S. Cross, P. Fasching, J. Olson, 2012, British Journal of Cancer.

Plus : development and validation of a prognostic model for early breast cancer that includes HER 2

T. Nielsen, M. García-Closas, G. Giles, 2012 .

Weibull regression with Bayesian variable selection to identify prognostic tumour markers of breast cancer survival

P J Newcombe, H Raza Ali, F M Blows, 2017, Statistical methods in medical research.

The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape

E Provenzano, C Caldas, J Miller, 2015, Cell Death and Disease.

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials

C. Caldas, E. Provenzano, H. Earl, 2012, British Journal of Cancer.

Explorer Adjuvant epirubicin followed by cyclophosphamide , methotrexate and fluorouracil ( CMF ) vs CMF in early breast cancer : results with over 7 years median follow-up from the randomised phase III NEAT / BR 9601 trials

C. Caldas, E. Provenzano, P. Pharoah, 2018 .